Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis

The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Nikunj J, Shah, Urmi N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129762/
https://www.ncbi.nlm.nih.gov/pubmed/21666322
http://dx.doi.org/10.4103/0301-4738.82005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129762/
https://www.ncbi.nlm.nih.gov/pubmed/21666322
http://dx.doi.org/10.4103/0301-4738.82005

Ejemplares similares